Search


 
Results 11 - 20 of about 24 for "FDA update".

Drug for chronic idiopathic constipation approved | ACP ...

The oral medication is taken once per day and works in the upper GI tract to stimulate secretion of intestinal fluid, supporting regular bowel function.

January 27, 2017 | ACP Gastroenterology Monthly

... IBS after infectious enteritis. FDA update. Drug for chronic idiopathic constipation approved. The oral medication is taken ...

March 24, 2017 | ACP Gastroenterology Monthly

... HIV co-infection. FDA update. IBS-D drug should not be prescribed to patients without gallbladders. The FDA suggests that ...

October 27, 2017 | ACP Gastroenterology Monthly

... eight years ago. FDA update. Warning issued on dosing of drug for primary biliary cholangitis. Clinicians should determine ...

Duodenoscopes recalled | ACP Gastroenterology Monthly

The recall of ED-530XT duodenoscopes by Fujifilm includes replacement of the ED-530XT forceps elevator mechanism (including the O-ring seal), ...

New HCV drug combo approved | ACP Gastroenterology ...

The fixed-dose tablet combines the previously approved drugs sofosbuvir and velpatasvir with a new drug, voxilaprevir.

Potency concerns lead to recall of anti-diarrhea drug | ACP ...

Recalled batches of diphenoxylate hydrochloride and atropine sulfate, an adjunctive therapy for the management of diarrhea, were distributed nationwide ...

May 26, 2017 | ACP Gastroenterology Monthly

... and case examples. FDA update. Regorafenib now FDA-approved to treat hepatocellular carcinoma. Approved use of the ...

Generic form of mesalamine approved | ACP ...

The drug is indicated to induce remission in adults with active, mild to moderate ulcerative colitis and to maintain remission of ulcerative colitis.

June 23, 2017 | ACP Gastroenterology Monthly

... patients with irritable bowel syndrome. FDA update. Generic form of mesalamine approved. The drug is indicated to induce ...

Result Page: < Previous  1 2 3  Next >